"I am a better investor because I am a businessman, and a better businessman because I am an investor."..Warren Buffet.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
KALLO INC. Signs Strategic Alliance Agreement with Petro Data Management Services Limited
Kallo (OTCBB:KALO)
Today : Thursday 8 December 2011
To enhance Kallo Inc.’s ability to address a global need for the provision of healthcare services in remote areas, the company has signed a formal agreement with PetroData Management Services Limited.
As part of Kallo’s global growth strategy, this agreement enables Kallo to bring the Mobile CareTM clinic to areas in great need of such healthcare services through locally known and reputed distributors. PetroData Management Services Limited will sell Kallo’s mobile clinic Mobile CareTM and provide local logistic and professional services for implementation and maintenance of the Mobile CareTM clinics.
“PetroData Management Services Limited has a well-earned reputation for excellence in data storage, management and customers service,” said John Cecil, CEO, Kallo Inc. “Moreover, we are confident that the company’s executive team, led by Chairman, Eng. Babajide Soyode, has the necessary regional credibility and reach to successfully represent our products and services in the Nigerian market – one that requires Kallo’s innovation to adequately provide healthcare services to remote communities. We look forward to a long and rewarding business relationship.”
“As per WHO, Nigeria has only 2.97 healthcare workers per 1000 population v/s a global average of 9.3,” said Eng. Babajide Soyode. “Through this relationship with Kallo, I am confident that we have the right mix of regional expertise and biomedical technologies needed, to address this urgent need and improve healthcare delivery in Nigeria’s remote communities, I am proud to be associated with Kallo Inc. – a company that I’ve come to know as one that has the right combination of insight, commitment and innovation required to meet the unique healthcare needs of the people of this great country,” said Eng. Babajide Soyode Chairman, PetroData Management Services Limited.
The above news has been filed as an 8K on November 1, 2011.
Nice volume. $12K is nothing to sneeze about 40 minutes into the day folks. KALO warming up here.
I got the heads up that this will be quiet until after the holidays. Not sure what happens after that,but my guess is at best some sort of awareness campaign or the unthinkable worse, an R/S that will leave the true longs dead in the water. Somewhere in between works for me to get out of this thing.
I will be posting home & email addresses and phone numbers for all the players involved in this thing after the first of the year.
That will be some I Box for sure.
VSTA NEWS OUT!! ~ VistaGen Therapeutics and Synterys Sign Strategic Medicinal Chemistry Collaboration Agreement for Drug Rescue
Vistagen Therapeutic (OTCBB:VSTA)
Today : Wednesday 7 December 2011
VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, and Synterys, Inc., a medicinal chemistry and collaborative drug discovery company, have entered into a strategic medicinal chemistry services agreement. The collaboration will further VistaGen's stem cell technology-based drug rescue initiatives with the support of Synterys' medicinal chemistry expertise.
VistaGen's drug rescue activities involve the combination of its human pluripotent stem cell technology platform, Human Clinical Trials in a Test Tube™, with modern medicinal chemistry to generate new chemical variants (drug rescue variants) of once-promising small molecule drug candidates that pharmaceutical companies, the U.S. National Institutes of Health (NIH) or university laboratories discontinued during preclinical development due to toxicity issues. VistaGen's drug rescue model leverages prior investment and preclinical development completed by others as well as the predictive toxicology and drug development capabilities of its stem cell technology platform.
"Our collaboration with Synterys directly supports the drug rescue applications of our Human Clinical Trials in a Test Tube™ platform," said Shawn Singh, VistaGen's Chief Executive Officer. "This strategic collaboration represents another important link in the ecosystem we are building around our cutting-edge technologies and innovations from industry and academia focused on transforming drug development."
"After evaluating several high quality candidates, we are happy to have selected Synterys as the medicinal chemistry partner of choice for our drug rescue programs," stated Ralph Snodgrass, Ph.D., President and Chief Scientific Officer of VistaGen. "Synterys' scientists bring significant experience in medicinal and synthetic organic chemistry to our collaboration, as well as the skills and infrastructure necessary to drive our programs forward successfully and cost effectively."
"We are very pleased to be entering into this collaborative relationship with VistaGen," commented John Kincaid, Synterys' founder. "Our company anticipates great success to result from the combination of VistaGen's stem cell technology platform and our decades of combined experience advancing compounds from early preclinical development into human clinical trials."
In addition to providing flexible, real-time medicinal chemistry services in support of VistaGen's drug rescue programs, the new agreement anticipates collaborations through which VistaGen and Synterys will identify novel drug rescue opportunities and drive them through preclinical development.
About VistaGen Therapeutics
VistaGen is a biotechnology company applying human pluripotent stem cell technology for drug rescue and cell therapy. Drug rescue involves the combination of human pluripotent stem cell technology with modern medicinal chemistry to generate new chemical variants of once-promising small molecule drug candidates that pharmaceutical companies have discontinued during preclinical or early clinical development due to heart or liver toxicity, despite positive efficacy data demonstrating their potential therapeutic and commercial benefits. VistaGen uses its pluripotent stem cell technology to generate early indications, or predictions, of how humans will ultimately respond to new drug candidates before they are ever tested in humans.
In parallel with its drug rescue activities, VistaGen is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform.
Additionally, VistaGen's small molecule drug candidate, AV-101, is in Phase 1 development for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S. alone. VistaGen plans to initiate Phase 2 clinical development of AV-101 in the fourth quarter of 2012. VistaGen is also exploring opportunities to leverage its current Phase 1 clinical program to enable additional Phase 2 clinical studies of AV-101 for epilepsy, Parkinson's disease and depression. To date, VistaGen has been awarded over $8.5 million from the NIH for development of AV-101.
Visit VistaGen at http://www.VistaGen.com, follow VistaGen at http://www.twitter.com/VistaGen or view VistaGen's Facebook page at http://www.facebook.com/VistaGen.
About Synterys
Synterys is a medicinal chemistry and collaborative drug discovery services company focused on meeting the needs of virtual and small drug discovery companies. Headquartered in Union City, California, Synterys has state-of-the-art laboratory facilities in the U.S. and Taiwan. The company's modern medicinal and synthetic chemistry infrastructure and capabilities, combined with its experienced team, provides the engine that drives its partners' programs to successful outcomes.
For more information on Synterys, visit http://www.Synterys.com.
Cautionary Statement Regarding Forward Looking Statements
The statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of VistaGen's ongoing clinical studies, including the safety and efficacy of its drug candidate, AV-101, the failure of future drug rescue and pilot preclinical cell therapy programs related to VistaGen's stem cell technology-based Human Clinical Trial in a Test Tube™ platform, its ability to enter into drug rescue collaborations, risks and uncertainties relating to the availability of substantial additional capital to support VistaGen's research, development and commercialization activities, and the success of its research, development, regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to AV-101 and any drug rescue variants identified and developed by VistaGen. These and other risks and uncertainties are identified and described in more detail in VistaGen's filings with the Securities and Exchange Commission (SEC). These filings are available on the SEC's website at www.sec.gov. VistaGen undertakes no obligation to publicly update or revise any forward-looking statements.
For More Information:
Shawn K. Singh, J.D.
Chief Executive Officer
VistaGen Therapeutics, Inc.
www.VistaGen.com
650-244-9990 x224
Investor.Relations@VistaGen.com
Mission Investor Relations
Atlanta, Georgia
http://www.MissionIR.com
404-941-8975
Investors@MissionIR.com
NEWS OUT!! ~ Herborium® Group Recent Social Marketing Campaign Grows Cyber Monday Sales 27%
Herborium Group (PC) (USOTC:HBRM)
Today : Wednesday 7 December 2011
Herborium Group, Inc., (PK: HBRM) is pleased to announce that its recently launched social media marketing campaign for its acne treatment, AcnEase®, is already producing positive results. Cyber Monday sales for AcnEase, the Company's flagship all botanical acne treatment, grew 27% as compared to 2010. The Company contributes this growth to the efforts being employed in the social media space to bring AcnEase to the consumers worldwide. Initial activities have included an updated FaceBook and Twitter presence, a new blog and third party representations in the beauty industry.
"We believe that this most satisfying increase in sales of AcnEase is just the beginning of the impact our strategies will have on sales. The extremely positive consumer response to the initial phase of our social media strategy is a strong indicator of future growth in revenues," commented Dr. Agnes P. Olszewski, President and CEO of Herborium.
"AcnEase is an all botanical ingredients based product that has proven effective for eliminating acne in both teenagers and adults of all ethnic groups with consumers with all skin types and colors benefiting from the results. AcnEase is safe and effective and can be used by both women and men without irritating, bleaching or discoloring the skin. As a result of this broad beneficial characteristics of AcnEase, Herborium has undertaken a number of initiatives to reach different –so far untapped ethnic markets of acne sufferers in the US and Europe. Our focus ending 2011 and going into 2012 will be on bringing those initiatives to fruition in terms of revenues," concluded Dr. Olszewski
About The $50 Billion Acne Market
Over 130 million individuals of all ethnic backgrounds are currently diagnosed with Acne in the USA and Europe alone with the $50 billion in revenues generated in acne treatments worldwide. For the past decade there is a steady growth in a total number of individuals suffering from acne and in sales acne treatments. New market needs are also emerging in this sector. Three most important of those trends became a special focus of Herborium marketing strategy: Increase in incidents of Adult Acne (over 17 million adults in the USA have acne) while most of acne treatments focus on teenagers; a growing demand for acne treatment suitable for all ethnic groups (while the supply of efficacious, targeted products in this category is almost non-existent); and the demand for truly natural and treatment that can provide satisfactory results.
About AcnEase (www.acnease.com)
AcnEase® is a proprietary, all herbal, systemically acting botanical therapeutic® targeting the symptoms of acne in both females and males of all ages. Unlike many herbal products, AcnEase has been validated through clinical testing. The results demonstrated that approximately 95% of the patients with adolescent acne responded positively to AcnEase. In adults with hormonal or chronic acne the level of effectiveness was 85%. The overall positive response rate to AcnEase was 91%. To date, after 5 plus years on the market, Herborium has registered a 95.5% consumer satisfaction rate for the AcnEase product.
About Herborium Group, Inc. (www.herborium.com)
Herborium Group, Inc., a botanical therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. The company secured a pipeline of botanical ingredients based products in the areas of Dermatology, Prostate Health (BPH), Liver Diseases and Women's and Men's Health and selected sexual disorders. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission
For more information please inquire: DrAgnes@Herborium.com
SOURCE Herborium Group, Inc.
Good point...one of 7 in the works! I forgot to DD that...thanks!!
From last week ~ ..Magnolia Solar Receives $750,000 Phase II Award From US Air Force Research Laboratory
Award Will Fund a Two-Year Program for Flexible, High-Efficiency Solar Cells
Press Release: Magnolia Solar, Inc. – Wed, Nov 30, 2011 4:30 PM EST.. .
WOBURN, MA and ALBANY, NY--(Marketwire -11/30/11)- Magnolia Solar Corporation (OTC.BB: MGLT.OB - News) ("Magnolia") announced today that its wholly owned subsidiary, Magnolia Solar, Inc., recently received a $750,000 Phase II award from the United States Air Force Research Laboratory as part of the Small Business Innovative Research (SBIR) program. The award will fund a two-year project to develop flexible, lightweight, ultra-high efficiency multi-junction solar cells for space power applications.
This award follows a Phase I program that demonstrated that Magnolia's approach to simultaneously increase the current and voltage output of photovoltaic devices for space power applications. The Phase II award is to optimize the device and apply advanced anti-reflective coatings to build ultra-high efficiency flexible solar power solutions for defense applications. Magnolia is building a patent portfolio around its proprietary technologies for this award and other work with government funding from the New York State Energy Research and Development Authority and the National Aeronautical Space Administration. Recently Magnolia announced demonstration of several significant milestones and this award provides a pathway to support its ultimate goal of developing low-cost, high-efficiency, thin-film solar cells for commercial and defense requirements.
Dr. Ashok K. Sood, President and CEO of Magnolia Solar Corporation, stated, "Photovoltaic devices can provide a mobile source of electrical power for a variety of military applications in space and terrestrial environments. Many of these applications can directly benefit from enhancements in the efficiency of the photovoltaic devices. In particular, flexible, lightweight, high-efficiency solar cells are needed to maximize the power-generating capability of space, ground-based, and air-based defense applications. The patent-pending technology developed during this program is expected to have immediate market opportunities for defense applications. We look forward to continuing our partnerships with MicroLink Devices and Rensselaer Polytechnic Institute during this Phase II program."
Dr. Roger E. Welser, Magnolia's Chief Technical Officer, observed, "Current approaches to increase the efficiency of multi-junction structures typically used for space power generation are reaching practical limitations due to fundamental constraints in conventional multi-junction device design. By combining wide and narrow bandgap material within each p-n junction, quantum-structured solar cells can overcome these constraints and increase the current and the voltage output of each subcell within a multi-junction solar cell. The Phase I effort leveraged the epitaxial liftoff process developed at MicroLink Devices in Niles, IL, and has demonstrated the validity of Magnolia's extended heterojunction photovoltaic device concept. Ultimately our approach provides a pathway for obtaining thin, flexible, multi-junction solar cells with efficiency approaching 40%."
About Magnolia Solar Corporation
Based in Woburn, MA and Albany, NY, Magnolia Solar was founded in 2008 to develop and commercialize revolutionary new thin film solar cell technologies that employ nanostructured materials and designs. Both higher current and voltage outputs are expected from thin film solar cells that combine Magnolia's exclusive material structures with advanced optical coatings. Magnolia's patent-pending technology has the ability to capture a larger part of the solar spectrum to produce high efficiency solar cells, and incorporates a unique nanostructure-based antireflection coating technology to further increase the solar cell's efficiency, thereby reducing the cost per watt. Magnolia Solar technology targets electrical power generation applications, such as power for electrical grids and distributed power applications ranging from commercial and residential lighting to specialized military applications.
For more information, please visit www.MagnoliaSolar.com, or visit us on Facebook, Twitter, You Tube, or LinkedIn.
Forward-Looking Statements
This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law.
.
.
Contact:.
.
For more information contact:
The Investor Relations Group
11 Stone St. 3rd Floor
New York, NY
212-825-3210
IR: Adam Holdsworth
PR: Enrique Briz
Email Contact
This is all about timing....SRPX is gonna go bigly one day, and I simply do not want to miss out on it...so I wait for the pop! It is coming sooner than later IMHO!
Hey j$tops....thanks. Good to be here. I follow you for the smart $$$....IMHO, this is a winner. I am getting peppered with IM's and PM's on KALO....I gotta see what the buzz is all about.
SRPX ~ AH News Out!! Scorpex Files Zoning Application
Scorpex (PC) (USOTC:SRPX)
Today : Wednesday 7 December 2011
Scorpex, Inc. (Pinksheets: SRPX) (the "Company"), an emerging leader of industrial, hazardous and toxic waste disposal services in the Baja Mexico/California region, filed its zoning application with the city of Ensenada, Mexico. The Company expects that this application will be accepted soon. Zoning of its initial site is necessary for the Company’s upcoming construction and operating plans. The Company believes that there will not be any extensive delays with its zoning application and development of the site.
Chief Executive Officer Joseph Caywood stated, “This particular zoning application is significant because it is a permanent zoning plan and should increase the value of the property dramatically. I do not expect any delays with the acceptance of the zoning application and we continue to achieve timely success with our governmental permits and applications.”
About Scorpex, Inc.
Scorpex, Inc. is taking the necessary steps to own and operate a full service waste disposal and recycling company, capable of storing and disposing all types of waste, including those classified as industrial, toxic, and hazardous. The location chosen for the first Scorpex plant is strategically positioned to accommodate the vast region of Baja California, Mexico.
For more information, visit www.scorpex.com
This press release may contain certain forward-looking statements regarding future circumstances. These forward-looking statements are based upon the Company's current expectations and assumptions and are subject to various risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. Actual results, events, and performance may differ. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. The Company undertakes no obligation to release publicly any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. The inclusion of any statement in this release does not constitute an admission by the Company or any other person that the events or circumstances described in such statements are material.
New mod here to join the HBRM party. Welcome Ichi back.
Lots of activity on the board tonight....looks like another winner here!!
Lots of $$ being spent here to push this one....could be a runner...not likely given the shortness of the paid promo, but hey. keep your eyes on KALO.....
Gotcha! I think I know who you are talking about....I have no idea where these folks came from or why the heck they are here, but I wish they would leave us alone...GLTY
Ain't just Quality Stocks going out on this thing. Lots of folks thought this would run, but the folks at CYTL spent their cash on a whole lotta nothing from the looks of this so far this week...only two trading days left in the week and this is not even warm....GLTY if you bought any of this one.
Well if his block is under 5K shares, they may not show him at all. Bump it to 5K shares and I would bet they show his order...JMHO and GLTY
I know I am looking for $.15 before I think of selling one share.
OTCQB & Float is less than 22M...that is nuts....This could be fun folks....
From OTC Markets..CYTL Security Details
Share Structure
Market Value1 $2,968,029 a/o Dec 02, 2011
Shares Outstanding 21,985,400 a/o Nov 22, 2011
Float 21,985,400 a/o Dec 02, 2011
Authorized Shares 200,000,000 a/o Nov 30, 2011
Par Value 0.0001
Shareholders
Shareholders of Record Not Available
Corporate Actions Ex. Date Record Date Pay Date
Security Notes
•Capital Change=shs decreased by 1 for 200 split. Pay date=08/14/2009.
Short Selling Data
Short Interest 0 (-100%)
Jun 30, 2011
Significant Failures to Deliver No
Transfer Agent(s)
Quicksilver Stock Transfer, LLC
Quality Stocks going out on CYTl tomorrow...Could be interesting to say the least.
SRPX...coverage initiated by Goldman....read on....Goldman Small Cap Research Initiates Coverage of Scorpex, Inc.
Scorpex, Inc. (USOTC:SRPX)
Today : Sunday 4 December 2011
Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, has initiated research coverage of Scorpex, Inc. (Pink Sheets:SRPX), an environmentally friendly waste services provider.
With a recent offer in hand to provide Scorpex with up to 800 tons of waste per day for disposal, the Company is positioned to become the dominant provider of integrated waste management services in the Baja regional market in Mexico that represents billions in annual revenue.
In the Goldman Opportunity Research report on the Company, analyst Rob Goldman outlines his investment thesis.
"Scorpex has no direct competition in this market as current methods of waste disposal are ineffective and costly with landfills overflowing. In fact, the primary current means of waste disposal is transportation to the U.S. and abroad. Once the Mexican contract is executed, Scorpex should generate substantial revenue and profitability, as the contract is worth hundreds of millions of dollars annually."
To view a summary of the report or download the report in its entirety, please visit
www.goldmanresearch.com
About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces small cap and micro cap stock market research reports and weekly investment newsletters. For more information, visit www.goldmanresearch.com.
A Goldman Small Cap Research report is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read the report's full disclosures and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer. To download our research, view our disclosures, or for more information, visit www.goldmanresearch.com.
About Scorpex, Inc. : Scorpex, Inc. (Pink Sheets:SRPX) is an environmentally friendly waste management services provider. Through its operations in Mexico, the Company will provide a comprehensive range of waste management services including the receipt, storage, transfer, recycling and disposal of waste in an environmentally sound manner. Scorpex's environmentally sound services are executed through the gasification and recycling of waste. Customers in Mexico shall include commercial, industrial, municipal and residential customers, other waste management companies, electric utilities and governmental entities. For more information, please visit www.scorpex.com.
CONTACT: Goldman Small Cap Research
Rob Goldman, Analyst
410-609-7100
rob@goldmanresearch.com
SRPX!! Keep it on your radar...Goldman is ....read on...Goldman Small Cap Research Initiates Coverage of Scorpex, Inc.
Scorpex, Inc. (USOTC:SRPX)
Today : Sunday 4 December 2011
Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, has initiated research coverage of Scorpex, Inc. (Pink Sheets:SRPX), an environmentally friendly waste services provider.
With a recent offer in hand to provide Scorpex with up to 800 tons of waste per day for disposal, the Company is positioned to become the dominant provider of integrated waste management services in the Baja regional market in Mexico that represents billions in annual revenue.
In the Goldman Opportunity Research report on the Company, analyst Rob Goldman outlines his investment thesis.
"Scorpex has no direct competition in this market as current methods of waste disposal are ineffective and costly with landfills overflowing. In fact, the primary current means of waste disposal is transportation to the U.S. and abroad. Once the Mexican contract is executed, Scorpex should generate substantial revenue and profitability, as the contract is worth hundreds of millions of dollars annually."
To view a summary of the report or download the report in its entirety, please visit
www.goldmanresearch.com
About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces small cap and micro cap stock market research reports and weekly investment newsletters. For more information, visit www.goldmanresearch.com.
A Goldman Small Cap Research report is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read the report's full disclosures and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer. To download our research, view our disclosures, or for more information, visit www.goldmanresearch.com.
About Scorpex, Inc. : Scorpex, Inc. (Pink Sheets:SRPX) is an environmentally friendly waste management services provider. Through its operations in Mexico, the Company will provide a comprehensive range of waste management services including the receipt, storage, transfer, recycling and disposal of waste in an environmentally sound manner. Scorpex's environmentally sound services are executed through the gasification and recycling of waste. Customers in Mexico shall include commercial, industrial, municipal and residential customers, other waste management companies, electric utilities and governmental entities. For more information, please visit www.scorpex.com.
CONTACT: Goldman Small Cap Research
Rob Goldman, Analyst
410-609-7100
rob@goldmanresearch.com
Goldman Small Cap Research Initiates Coverage of Scorpex, Inc.
Scorpex, Inc. (USOTC:SRPX)
Today : Sunday 4 December 2011
Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, has initiated research coverage of Scorpex, Inc. (Pink Sheets:SRPX), an environmentally friendly waste services provider.
With a recent offer in hand to provide Scorpex with up to 800 tons of waste per day for disposal, the Company is positioned to become the dominant provider of integrated waste management services in the Baja regional market in Mexico that represents billions in annual revenue.
In the Goldman Opportunity Research report on the Company, analyst Rob Goldman outlines his investment thesis.
"Scorpex has no direct competition in this market as current methods of waste disposal are ineffective and costly with landfills overflowing. In fact, the primary current means of waste disposal is transportation to the U.S. and abroad. Once the Mexican contract is executed, Scorpex should generate substantial revenue and profitability, as the contract is worth hundreds of millions of dollars annually."
To view a summary of the report or download the report in its entirety, please visit
www.goldmanresearch.com
About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces small cap and micro cap stock market research reports and weekly investment newsletters. For more information, visit www.goldmanresearch.com.
A Goldman Small Cap Research report is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read the report's full disclosures and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer. To download our research, view our disclosures, or for more information, visit www.goldmanresearch.com.
About Scorpex, Inc. : Scorpex, Inc. (Pink Sheets:SRPX) is an environmentally friendly waste management services provider. Through its operations in Mexico, the Company will provide a comprehensive range of waste management services including the receipt, storage, transfer, recycling and disposal of waste in an environmentally sound manner. Scorpex's environmentally sound services are executed through the gasification and recycling of waste. Customers in Mexico shall include commercial, industrial, municipal and residential customers, other waste management companies, electric utilities and governmental entities. For more information, please visit www.scorpex.com.
CONTACT: Goldman Small Cap Research
Rob Goldman, Analyst
410-609-7100
rob@goldmanresearch.com
CYTL getting ready for a big push this week. A lot of big groups going out on it. Look for some huge posting starting on this one later today.
About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces small cap and micro cap stock market research reports and weekly investment newsletters. For more information, visit www.goldmanresearch.com.
A Goldman Small Cap Research report is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read the report's full disclosures and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer. To download our research, view our disclosures, or for more information, visit
www.goldmanresearch.com.
In the Goldman Opportunity Research report on the Company, analyst Rob Goldman outlines his investment thesis.
"Scorpex has no direct competition in this market as current methods of waste disposal are ineffective and costly with landfills overflowing. In fact, the primary current means of waste disposal is transportation to the U.S. and abroad. Once the Mexican contract is executed, Scorpex should generate substantial revenue and profitability, as the contract is worth hundreds of millions of dollars annually."
Sunday 12/4 SRPX HUGE NEWS!! Goldman Small Cap Research Initiates Coverage of Scorpex, Inc.
Scorpex, Inc. (USOTC:SRPX)
Today : Sunday 4 December 2011
Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, has initiated research coverage of Scorpex, Inc. (Pink Sheets:SRPX), an environmentally friendly waste services provider.
With a recent offer in hand to provide Scorpex with up to 800 tons of waste per day for disposal, the Company is positioned to become the dominant provider of integrated waste management services in the Baja regional market in Mexico that represents billions in annual revenue.
In the Goldman Opportunity Research report on the Company, analyst Rob Goldman outlines his investment thesis.
"Scorpex has no direct competition in this market as current methods of waste disposal are ineffective and costly with landfills overflowing. In fact, the primary current means of waste disposal is transportation to the U.S. and abroad. Once the Mexican contract is executed, Scorpex should generate substantial revenue and profitability, as the contract is worth hundreds of millions of dollars annually."
To view a summary of the report or download the report in its entirety, please visit
www.goldmanresearch.com
About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces small cap and micro cap stock market research reports and weekly investment newsletters. For more information, visit www.goldmanresearch.com.
A Goldman Small Cap Research report is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read the report's full disclosures and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer. To download our research, view our disclosures, or for more information, visit www.goldmanresearch.com.
About Scorpex, Inc. : Scorpex, Inc. (Pink Sheets:SRPX) is an environmentally friendly waste management services provider. Through its operations in Mexico, the Company will provide a comprehensive range of waste management services including the receipt, storage, transfer, recycling and disposal of waste in an environmentally sound manner. Scorpex's environmentally sound services are executed through the gasification and recycling of waste. Customers in Mexico shall include commercial, industrial, municipal and residential customers, other waste management companies, electric utilities and governmental entities. For more information, please visit www.scorpex.com.
CONTACT: Goldman Small Cap Research
Rob Goldman, Analyst
410-609-7100
rob@goldmanresearch.com
CFGX, spread is now 35%...come on man! That is nuts....eom
18K shares until $.90 is up. JMHO, but that is really thin.
Me too Blue....$.75 would be a good close today heading into the weekend.
Looks darn good from here Jsmitty111...I am in it to win it!! Looks like another Blue Winner!!
Great news release Blue...Looks like we are building for something huge around here....
"I SURE HAD A LOT OF FUN BIDDING TODAY.... *727*"
Hey Blue_...I will take 14K Dollars as a trickle any day of the week...a little more volume and who knows where SRPX lands PPS wise....GLTA
This is why the spread needs to tighten, why would someone sell into a 26% spread....SHEESH!
I already reported him to Admin for TOU violations here and elsewhere. No clue why or what he is doing with those posts.
RICK NEWS! Former NBA Great Spud Webb Named Coach of Rick's Cabaret/New York Stripper Basketball Team
Ricks Cabaret International, Inc. (MM) (NASDAQ:RICK)
Today : Wednesday 30 November 2011
Former NBA Great Spud Webb Named Coach of Rick's Cabaret/New York Stripper Basketball Team
PR Newswire
NEW YORK, Nov. 29, 2011
NEW YORK, Nov. 29, 2011 /PRNewswire/ -- Former Atlanta Hawks National Basketball Association sensation Anthony "Spud" Webb has accepted his latest challenge – coach of a newly formed team of shapely women from Rick's Cabaret/New York City. Webb was introduced to the media at a news conference today at the gentlemen's club Playboy.com called the "No. 1 strip club in New York."
(Logo: http://photos.prnewswire.com/prnh/20110418/MM85342LOGO)
The sexy women's team was formed to give fans an entertaining option during the delay in getting the NBA season underway. The "Rick's Basketball Association" is comprised of squads from Rick's Cabaret International, Inc. (NASDAQ:RICK), the publicly traded group of 23 upscale gentlemen's clubs that are popular with pro athletes and their fans.
The 5'7" Webb overcame multiple challenges to earn a spot with the Hawks and then the Sacramento Kings in the 1980s and 90s, becoming one of the most admired players in the league, famed for his amazing four-foot leaps and dunking ability. Despite his diminutive size, he averaged over 10 points and five assists a game, played in several playoff series and won the slam-dunk championship at the 1986 All-Star game, beating out Dominique Wilkins and Michael Jordan. After retirement as a player, became an executive of the Texas Legends, a NBA Development League team and is a popular motivational speaker.
Rick's Cabaret introduced Webb to the media at a news conference at the New York City club today, at which he put his team through a practice session in front of the stage where they normally dance. The New York team is expected to play games shortly against the Minneapolis Downtown Cabaret and Tootsie's Cabaret in Miami.
"These ladies are fabulous and have obvious talents and skills. I can't think of a better way to entertain long-suffering NBA fans," Webb said.
"He's a hero to people of all sizes and he shows that anyone can accomplish anything," said Gianna, a point guard on the New York team. "Of course we are happy the NBA is coming back in December--they are some of our best customers. We'll play 'til the NBA season starts because our fans and customers want it."
About Rick's Cabaret: Rick's Cabaret International, Inc. (NASDAQ: RICK) is home to 23 upscale adult nightclubs serving primarily businessmen and professionals that offer live entertainment, dining and bar operations. Nightclubs in New York City, Miami, Philadelphia, Charlotte, Dallas, Houston, Minneapolis and other cities operate under the names "Rick's Cabaret," "XTC," "Club Onyx" and "Tootsie's Cabaret". Sexual contact is not permitted at these locations. Rick's Cabaret also operates a media division, ED Publications, and owns the adult Internet membership Website couplestouch.com as well as a network of online adult auction sites under the flagship URL naughtybids.com. Rick's Cabaret common stock is traded on NASDAQ under the symbol RICK. For further information contact ir@ricks.com or visit www.ricksinvestor.com.
SOURCE Rick's Cabaret International, Inc.
It was great news indeed Blue, I think the momentum is just starting to build on this one.
About Premier Beverage Group
Premier Beverage Group (OTC: PBGC) is a holding company that – through its subsidiary, OSO Beverages – owns, develops, markets and distributes high-end premium functional beverages. Premier Beverage Group's flagship brand, OSO, is a premium energy beverage offered primarily to on-premise accounts. OSO – offered in both regular and sugar-free flavors – is produced in Austria, using only the finest ingredients – resulting in a clear, crisp energy beverage and an up-market consumer experience. For more information on Premier Beverage Group, please visit www.premierbeveragegroup.com. For more information on OSO Beverages, please visit www.osobeverages.com.
This press release, within the meaning of the Private Securities Litigation Reform Act of 1995, contains forward-looking statements involving known and unknown risks, delays, and uncertainties that may cause our actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks, delays, and uncertainties include, but are not limited to: risks associated with the uncertainty of future financial results, our reliance on a limited number of suppliers, the limited diversification of our product offerings, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, as well as the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.